Javascript must be enabled to continue!
Expression of Estrogen and Progesterone Receptor In Perimenopausal and Postmenopausal Endometrium.
View through CrossRef
Background: Hormonal changes during the menopausal transition significantly influence breast tissue biology. Estrogen receptor (ER) and progesterone receptor (PR) expression are critical markers in breast pathology and significantly impact prognosis and treatment in hormone-responsive breast conditions. This study aimed to evaluate and compare ER and PR expression in perimenopausal and postmenopausal women presenting with breast lesions.
Objective: The aim of the study is to examine the degree of expression of ER and PR in the endometrium of women with perimenopausal and postmenopausal bleeding.
Methods: 50 endometrial biopsy and hysterectomy specimens of perimenopausal and postmenopausal bleeding from the department of obstetrics and gynaecology of RRMCH after routine tissue processing, tissue sections will be stained immunohistochemically for ER and PR receptor expression as per standard procedure with the combination of pathnsitu protocol and pressure cooker antigen retrieval (tris-EDTA buffer- pH 6) and Allred scoring system was used for interpretation.
Results: In the present study, majority of the patients belong to the age group 40 - 45 years (66%). The mean age of the patients was found to be 46.80 + 6.84. All the patients with Proliferative endometrium, disordered proliferative endometrium, cystic atrophy endometrium & lytic endometrium were 100% positive for ER, followed by hyperplasia without atypia 87.5% and secretory endometrium 80%, atypical hyperplasia 66.6% and carcinoma endometrium 50.0%. All the patients with Proliferative endometrium, disordered proliferative endometrium, cystic atrophy endometrium, lytic endometrium were 100% positive for PR, followed by hyperplasia without atypia 87.5% and secretory endometrium 80%, atypical hyperplasia 66.6% and carcinoma endometrium 62.4%. A declining trend in receptor positivity was noted with advancing age and menopausal status, although not statistically significant in all subgroups.
Conclusion: ER and PR expression is more frequently observed in perimenopausal women compared to postmenopausal women. Analysis of steroid hormone receptors plays an important role in patients with perimenopausal and postmenopausal bleeding to predict the response to hormonal therapy
Global Edge Printers and Publishers
Title: Expression of Estrogen and Progesterone Receptor In Perimenopausal and Postmenopausal Endometrium.
Description:
Background: Hormonal changes during the menopausal transition significantly influence breast tissue biology.
Estrogen receptor (ER) and progesterone receptor (PR) expression are critical markers in breast pathology and significantly impact prognosis and treatment in hormone-responsive breast conditions.
This study aimed to evaluate and compare ER and PR expression in perimenopausal and postmenopausal women presenting with breast lesions.
Objective: The aim of the study is to examine the degree of expression of ER and PR in the endometrium of women with perimenopausal and postmenopausal bleeding.
Methods: 50 endometrial biopsy and hysterectomy specimens of perimenopausal and postmenopausal bleeding from the department of obstetrics and gynaecology of RRMCH after routine tissue processing, tissue sections will be stained immunohistochemically for ER and PR receptor expression as per standard procedure with the combination of pathnsitu protocol and pressure cooker antigen retrieval (tris-EDTA buffer- pH 6) and Allred scoring system was used for interpretation.
Results: In the present study, majority of the patients belong to the age group 40 - 45 years (66%).
The mean age of the patients was found to be 46.
80 + 6.
84.
All the patients with Proliferative endometrium, disordered proliferative endometrium, cystic atrophy endometrium & lytic endometrium were 100% positive for ER, followed by hyperplasia without atypia 87.
5% and secretory endometrium 80%, atypical hyperplasia 66.
6% and carcinoma endometrium 50.
0%.
All the patients with Proliferative endometrium, disordered proliferative endometrium, cystic atrophy endometrium, lytic endometrium were 100% positive for PR, followed by hyperplasia without atypia 87.
5% and secretory endometrium 80%, atypical hyperplasia 66.
6% and carcinoma endometrium 62.
4%.
A declining trend in receptor positivity was noted with advancing age and menopausal status, although not statistically significant in all subgroups.
Conclusion: ER and PR expression is more frequently observed in perimenopausal women compared to postmenopausal women.
Analysis of steroid hormone receptors plays an important role in patients with perimenopausal and postmenopausal bleeding to predict the response to hormonal therapy.
Related Results
Relationship Of FEF<sub>25-75</sub>, Pefr And SVC With Estrogen And Progesterone Level In Postmenopausal Women
Relationship Of FEF<sub>25-75</sub>, Pefr And SVC With Estrogen And Progesterone Level In Postmenopausal Women
Background: Deterioration of lung function is common in women after menopause, which may be related to very low estrogen and progesterone level. Objective: To observe FEF25-75, PEF...
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
Abstract
Objective
This study aimed to distinguish ex-vivo normal and abnormal endometrium tissue samples histologically by catheter based optical c...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Endometrial progesterone receptor expression during the human menstrual cycle
Endometrial progesterone receptor expression during the human menstrual cycle
Abstract
The human endometrium undergoes regular cyclical changes under the endocrine control of oestrogens and progesterone acting via specific nuclear receptors...
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract
Background: Previous research has highlighted the paradoxical nature of estrogen in both contributing to and reducing the risk of breast cancer. Exposure to...
P-627 Premature Progesterone increase during the luteal phase was not associated with the Follicular Output Rate (FORT)
P-627 Premature Progesterone increase during the luteal phase was not associated with the Follicular Output Rate (FORT)
Abstract
Study question
Is premature follicular progesterone increase associated with the Follicular Output Rate (FORT) during c...
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract
Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Estrogen Signaling and Cardiovascular Disease
Estrogen Signaling and Cardiovascular Disease
Estrogen has pleiotropic effects on the cardiovascular system. The mechanisms by which estrogen confers these pleiotropic effects are undergoing active investigation. Until a decad...

